Lucid Diagnostics Inc reports results for the quarter ended in September - Earnings Summary

Lucid Diagnostics

15/11/2022 24:26

* Lucid Diagnostics Inc  LUCD.OQ  reported a quarterly
adjusted
loss of 39 cents​​ per share for the quarter ended in September.
The mean expectation of five analysts for the quarter was for a
loss of 40 cents per share.
    * Revenue fell 62% to $76.00 thousand from a year ago;
analysts
expected $425.00 thousand. 
    * Lucid Diagnostics Inc's reported EPS for the quarter was a
loss
of 39 cents​.
    * The mean earnings estimate of analysts had fallen by
about 7.9%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Lucid Diagnostics Inc shares had risen by 45.8% this
quarter and
lost 58.5% so far this year.
    * The company reported a quarterly loss of $14.35 million.
    * Wall Street's median 12-month price target for Lucid
Diagnostics
Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
15 at 12:26 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.40          -0.39          Beat
 Jun. 30 2022      -0.36          -0.41          Missed
 Mar. 31 2022      -0.33          -0.35          Missed
 Dec. 31 2021      -0.20          -0.32          Missed